Vir Biotechnology (VIR) Asset Utilization Ratio (2019 - 2026)

Vir Biotechnology (VIR) has 8 years of Asset Utilization Ratio data on file, last reported at 0.06 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 319.29% year-over-year to 0.06; the trailing twelve-month figure through Mar 2026 stood at 0.06 (up 319.29% YoY), and the FY2025 full-year result was 0.06, up 27.63% from the prior year.
• Asset Utilization Ratio retreated to 0.06 in Q1 2026, from 0.07 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.96 in Q1 2022 to a low of 0.02 in Q2 2025.
• A 5-year average of 0.24 and a median of 0.06 in 2023 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio soared 1909.12% in 2022 and tumbled 94.02% in 2023, its largest moves.
• Tracing VIR's Asset Utilization Ratio over 5 years: stood at 0.62 in 2022, then plunged by 92.96% to 0.04 in 2023, then climbed by 10.39% to 0.05 in 2024, then surged by 41.26% to 0.07 in 2025, then dropped by 4.67% to 0.06 in 2026.
• Business Quant data shows VIR's Asset Utilization Ratio at 0.06 in Q1 2026, 0.07 in Q4 2025, and 0.02 in Q3 2025.